What Happened?
South San Francisco, CA-based Nkarta Therapeutics Promoted Ralph Brandenberger as Chief Technical Officer
About the Company
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body.
About the Person
Ralph Brandenberger is Chief Technical Officer at Nkarta Therapeutics. Previously, Ralph held various senior IT leadership roles in the industry.
Info Source
News
Short Profile